Zusammenfassung
Neurologische Symptome bei erworbenen metabolischen Störungen sind selten charakteristisch und setzen daher das Verständnis pathophysiologischer Zusammenhänge voraus. Die hypothesengesteuerte Differentialdiagnose und der gezielte Einsatz von apparativen Zusatzuntersuchungen sind besonders bei diesen kritisch kranken Patienten erforderlich. Nach Diagnosestellung zielt die Therapie weitgehend auf die Grunderkrankung. Um den Rahmen dieses Kapitels nicht zu sprengen, werden nur die wichtigsten erworbenen metabolischen Enzephalopathien und deren interdisziplinäres Management vorgestellt.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Adrogue H, Madias NE (1998) Management of life-threatening acid-base disorders. First of two parts. N Engl J Med 338:26–34.
Adrogue H, Madias NE (1998) Management of life-threatening acid-base disorders. Second of two parts. N Engl J Med 338:107–111.
Auer RN (1986) Progress review: Hypoglycémic brain damage. Stroke 17:699–708.
Bilezikian JP (1989) Etiologies and therapy of hypercalcemia. Endocrinol Metab Clin North Am 18:389–414.
Bilezikian JP (1988) Hypercalcemia. Dis Mon 34:737–799.
Bourke E, Delaney V (1993) Assessment of hypocalcemia and hypercalcemia. Clin Lab Med 13:157–181.
Butterworth RF (1996) The neurobiology of hepatic encephalopathy. Seminars in Liver Disease 3:235–244.
Calabresi P, Pisani A, Mercuri NB, Bernardi G (1995) On the mechanisms underlying hy-poxia-induced depolarization in striatal neurons. Brain 118:1027–1038.
Cooper DJ, Walley KR, Wiggs BR (1990) Bicarbonat does not improve hemodynamics in critically ill patients who have lactic acidocis. Ann Intern Med 112:492–498.
Della Porta P, Maiolo AT, Negri VU (1964) Cerebral blood flow and metabolism in therapeutic insulin coma. Metabolism 13:131–140.
Fraser CL, Arieff AI (1997) Epidemiology, Pathophysiology, and Management of Hyponatremic Encephalopathy. Am J Med 102:67–77.
Fraser CL, Swanson RA (1994) Female sex hormones inhibit volume regulation in rat brain astrocyte culture. Am J Physiol (Cell Physiol 36) 267:C909–C914.
Fujioka M, Okuchi K, Hiramatsu K, Sakaki T, Sakaguchi S, Ishii Y (1997) Specific changes in human brain after hypoglycémie injury. Stroke 28:584–587
Herrera L, Kazemi H (1980) CSF bicarbonate regulation in metabolic acidosis: Role of HCO3 formation in CSF. J Appi Physiol 49:778–783.
Hinchey J, Chaves C, Appignani B et al. (1996) A reversible posterior leukencephalopathy syndrome. N Engl J Med 334:494–500
Iwai A, Sakamoto T, Kinoshita Y et al. (1987) Computed tomographic imaging of the brain after hypoglycémie coma. Neuroradiology 29:398–400.
Johansson BB (1983) The blood-brain barrier and cerebral blood flow in acute hypertension. Acta Med Scand Suppl 678:107–112.
Kitabchi AE, Murphy MB (1988) Diabetic ketoacidosis and hyperosmolar hyperglycémic non-ketotic coma. Med Clin N Am 72:1545–1560.
Krieger D, Krieger S, Jansen O et al. (1995) Manganese and chronic hepatic encephalopathy. Lancet 346:270–274.
Krieger S, Jauß M, Jansen O, Theilmann L, Geißler M, Krieger D (1996) Neuropsychiatrie profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis. Gastroenterology 111:147–155.
Lassen NA (1974) Control of cerebral circulation in health and disease. Circ Res 34:79–760.
Lee JH, Arcinue E, Ross BD (1994) Brief report: organic osmolytes in the brain of an infant with Hypernatremia. N Engl J Med 331:439–442.
McManus ML, Churchwell KB, Strange K (1995) Regulation of cell volume in health and disease. N Engl J Med 333:1260–1266.
Miller AL (1985) Carbon dioxide narcosis. In: McCandless DW (ed) Cerebral energy metabolism and metabolic encephalopathy. Plenum Press, New York, pp 143–162.
Mundy GR (1990) Incidence and pathophysiology of hypercalcemia. Calcif Tissue Int 46 (Suppl):3–10.
Norenberg MD (1983) A hypothesis of osmotic endothelial injury. Arch Neurol 40:66–69.
Ohlinger ML (1989) Disorders of calcium and magnesium metabolism. Emerg Med Clin North Am 7:795–822.
O’Grady JG, Alexander GJM, Hayllar KM, Williams R (1989) Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97:439–445.
Patten BM, Bilezikian JP, Mallette LE (1974) Neuromuscular disease in primary hyperpara-thyroidism. Ann Int Med 80:182–193.
Riordan SM, Williams R (1997) Treatment of hepatic encephalopathy. N Engl J Med 337:473–479.
Tien R, Arieff AI, Kucharczyk W et al. (1992) Hyponatremic encephalopathy: Is central pontine myelinolysis a component? Am J Med 92:513–522.
Wijdicks EFM, Plevak DJ, Rakela J, Wiesner RH (1995) Clinical and radiologic features of cerebral edema in fulminant hepatic failure. Mayo Clin Proc 70:119–124.
Zaloga GP (1992) Hypocalcemia in critical ill patients. Crit Care Med 20:251–262.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Krieger, S., Petros, S., Berrouschot, J., Krieger, D. (1999). Enzephalopathien bei erworbenen metabolischen Erkrankungen. In: Schwab, S., Krieger, D., Müllges, W., Hamann, G., Hacke, W. (eds) Neurologische Intensivmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-58415-2_31
Download citation
DOI: https://doi.org/10.1007/978-3-642-58415-2_31
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63583-0
Online ISBN: 978-3-642-58415-2
eBook Packages: Springer Book Archive